All Updates

All Updates

icon
Filter
Funding
Management news
Healthy.io closes USD 50 million Series D; lays off one-third of workforce
Preventive Healthcare
May 3, 2023
This week:
Funding
Matr Foods raises EUR 20 million in debt funding to build mycelium meat factory
Plant-based Meat
Today
Last week:
M&A
Platform Science to acquire Trimble's global transportation telematics business units
Truck Industry Tech
Yesterday
Funding
Whatfix raises USD 100 million in Series E funding to expand business
EdTech: Corporate Learning
Yesterday
Product updates
Sky Mavis launches cross-game onboarding solution
Web3 Ecosystem
Sep 14, 2024
Funding
Bicara Therapeutics raises USD 315 million in IPO; plans to develop lead candidate ficerafusp alfa
Precision Medicine
Sep 13, 2024
Partnerships
Massive Bio and Foundation Medicine partner to improve cancer clinical trial enrollment
Precision Medicine
Sep 13, 2024
Partnerships
Moffitt Cancer Center partners with AstraZeneca to advance oncology cell therapies
Cell & Gene Therapy
Sep 13, 2024
Product updates
Quandela launches European quantum computer in North America
Quantum Computing
Sep 13, 2024
Partnerships
IonQ achieves high qubit gate fidelity on barium development platform
Quantum Computing
Sep 13, 2024
Partnerships
Massive Bio and Foundation Medicine partner to improve cancer clinical trial enrollment
Clinical Trial Technology
Sep 13, 2024
Preventive Healthcare

Preventive Healthcare

May 3, 2023

Healthy.io closes USD 50 million Series D; lays off one-third of workforce

Funding
Management news

  • Passive remote patient monitoring system Healthy.io has closed a Series D funding round raising USD 50 million, which includes an unannounced USD 45 million investment in February 2022. The round was led by Schusterman Family Investments, with participation from Aleph and other existing shareholders. 

  • The proceeds will be used to expand the company’s operations in the US, in relation to which Healthy.io laid off one-third of its workforce (roughly 70 employees who were predominantly based in the Israel and UK). 

  • The Israeli company offers clinical-grade urinalysis diagnostic testing, which can be accessed from the comfort of one's home. Users can quickly obtain their results anytime and anywhere by using their smartphones. The results are shared securely with their healthcare providers for follow-ups. Having received FDA approval in 2018, the company recently received FDA 510(k) clearance for its Minuteful Kidney test.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.